Safety of gadolinium‐based contrast material in sickle cell disease
dc.contributor.author | Dillman, Jonathan R. | en_US |
dc.contributor.author | Ellis, James H. | en_US |
dc.contributor.author | Cohan, Richard H. | en_US |
dc.contributor.author | Caoili, Elaine M. | en_US |
dc.contributor.author | Hussain, Hero K. | en_US |
dc.contributor.author | Campbell, Andrew D. | en_US |
dc.contributor.author | Strouse, Peter J. | en_US |
dc.date.accessioned | 2011-11-10T15:37:34Z | |
dc.date.available | 2012-12-03T21:17:30Z | en_US |
dc.date.issued | 2011-10 | en_US |
dc.identifier.citation | Dillman, Jonathan R.; Ellis, James H.; Cohan, Richard H.; Caoili, Elaine M.; Hussain, Hero K.; Campbell, Andrew D.; Strouse, Peter J. (2011). "Safety of gadolinium‐based contrast material in sickle cell disease." Journal of Magnetic Resonance Imaging 34(4): 917-920. <http://hdl.handle.net/2027.42/87070> | en_US |
dc.identifier.issn | 1053-1807 | en_US |
dc.identifier.issn | 1522-2586 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/87070 | |
dc.description.abstract | Purpose: To assess the safety of intravenously administered gadolinium‐based contrast material in sickle cell disease (SCD) patients. Materials and Methods: All pediatric and adult SCD patients evaluated by magnetic resonance imaging (MRI) at our institution between January 1995 and July 2009 were identified. The medical records of SCD patients who underwent contrast‐enhanced MRI as well as an equal‐sized cohort of SCD patients who underwent unenhanced MRI were reviewed for adverse (vaso‐occlusive and hemolytic) events within 1 week following imaging. Results: Eight (five mild and three moderate) adverse events were documented within 1 week following contrast‐enhanced MRI (38 patients and 61 contrast injections), while six (five mild and one moderate) similar events occurred within 1 week following unenhanced MRI (61 patients and 61 unenhanced MRI examinations). This difference in the number of adverse events was not statistically significant (odds ratio = 1.4; 95% confidence interval [CI] 0.4, 5.2). No severe adverse event occurred in either patient cohort. Conclusion: Gadolinium‐based contrast materials do not appear to be associated with increased risk of vaso‐occlusive or hemolytic adverse events when administered to SCD patients. Larger, prospective studies using multiple gadolinium‐based contrast materials would be useful to confirm the results of our investigation. J. Magn. Reson. Imaging 2011;. © 2011 Wiley‐Liss, Inc. | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Magnetic Resonance Imaging (MRI) | en_US |
dc.subject.other | Gadolinium‐Based Contrast Material (GBCM) | en_US |
dc.subject.other | Sickle Cell Disease | en_US |
dc.subject.other | Adverse Event | en_US |
dc.title | Safety of gadolinium‐based contrast material in sickle cell disease | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Radiology, Section of Pediatric Radiology, C.S. Mott Children's Hospital, University of Michigan Health System, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Department of Radiology, Division of Abdominal Imaging, University of Michigan Health System, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Department of Pediatrics and Communicable Diseases, University of Michigan Health System, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | University of Michigan Health System, C.S. Mott Children's Hospital/F3503, Department of Radiology, Section of Pediatric Radiology, 1500 E. Medical Center Dr., Ann Arbor, MI 48109‐5252 | en_US |
dc.identifier.pmid | 21769966 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/87070/1/22666_ftp.pdf | |
dc.identifier.doi | 10.1002/jmri.22666 | en_US |
dc.identifier.source | Journal of Magnetic Resonance Imaging | en_US |
dc.identifier.citedreference | OptiMark [package insert]. St. Louis, MO: Mallinckrodt Inc.; 2009. | en_US |
dc.identifier.citedreference | ProHance [package insert]. Princeton, NJ: Bracco Diagnostics Inc.; 2007. | en_US |
dc.identifier.citedreference | Umans H, Haramati N, Flusser G. The diagnostic role of gadolinium enhanced MRI in distinguishing between acute medullary bone infarct and osteomyelitis. Magn Reson Imaging 2000; 18: 255 – 262. | en_US |
dc.identifier.citedreference | Westwood MA, Shah F, Anderson LJ, et al. Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy. J Magn Reson Imaging 2007; 26: 564 – 568. | en_US |
dc.identifier.citedreference | Tzika AA, Massoth RJ, Ball WS Jr, et al. Cerebral perfusion in children: detection with dynamic contrast‐enhanced T2*‐weighted MR images. Radiology 1993; 187: 449 – 458. | en_US |
dc.identifier.citedreference | Kirkham FJ, Calamante F, Bynevelt M, et al. Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol 2001; 49: 477 – 485. | en_US |
dc.identifier.citedreference | Grueneich R, Ris MD, Ball W, et al. Relationship of structural magnetic resonance imaging, magnetic resonance perfusion, and other disease factors to neuropsychological outcome in sickle cell disease. J Pediatr Psychol 2004; 29: 83 – 92. | en_US |
dc.identifier.citedreference | Zimmerman RA. MRI/MRA evaluation of the brain. Pediatr Radiol 2005; 35: 249 – 257 | en_US |
dc.identifier.citedreference | American College of Radiology. Manual on contrast media, version 7. http://www.acr.org/secondarymainmenucategories/quality_safety/contrast_manual.aspx Accessed Dec. 12, 2010. | en_US |
dc.identifier.citedreference | Brody AS, Sorette MP, Gooding CA, et al. Induced alignment of flowing sickle erythrocytes in a magnetic field: a preliminary report. Invest Radiol 1985; 20: 560 – 566. | en_US |
dc.identifier.citedreference | Kanal E, Shellock FG, Talagala L. Safety considerations in MR imaging. Radiology 1990; 176: 593 – 606. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.